Equity by Design in Clinical Research: A Six-Part Course
Welcome to EQUITY BY DESIGN IN CLINICAL RESEARCH: A SIX-PART COURSE, a training course to advance diversity, equity, and inclusion (DEI) of underrepresented populations in clinical trials and is applicable to clinical research across all health areas. Ethical and regulatory considerations are included, and practical guidance for commitment, communication, partnership, and conduct is emphasized.
This course is a six-part series. It was originally conducted as a live virtual course (titled Equity by Design in Clinical Research: Cancer Trials) and has been reformatted as an online course. All modules begin with a 45-minute recorded instructional session, followed by a 45-minute recorded discussion session with leaders in the field. Each module also contains: transcripts for each recorded session, a PDF of the instructional session slides, and a list of resources referenced in the lecture.
- Module 1 : Commitment to DEI
- Module 2 : Community Engagement and Representation
- Module 3 : Study Planning and Communications
- Module 4 : Study Conduct
- Module 5 : Workforce Development
- Module 6 : Accountability, Advocacy, and Justice
This activity is intended for leadership, investigators, practicing providers, clinical trialists, clinical trials staff, nurse practitioners, nurses, research nurse specialists, physician assistants, clinical research coordinators, other frontline staff, regulatory and IRB committee members, and others who design, conduct, report are are responsible for clinical research.
Please see the individual modules. Each module has detailed learning objectives.
PLEASE NOTE: For questions or assistance with any special needs regarding the training course, please contact the MRCT Center at: MRCT@bwh.harvard.edu
Many thanks to the following people for their work in developing this training series:
Dr. Barbara Bierer, Faculty Director, Multi-Regional Clinical Trials Center of Brigham & Women’s Hospital & Harvard: Course instructor and discussion session moderator
Ms. Hayat Ahmed, Project Manager, Multi-Regional Clinical Trials Center of Brigham & Women’s Hospital & Harvard
Dr. Willyanne DeCormier Plosky, Program Manager, Multi-Regional Clinical Trials Center of Brigham & Women’s Hospital & Harvard
Ms. Laura Meloney, Program Manager, Multi-Regional Clinical Trials Center of Brigham & Women’s Hospital & Harvard
Ms. Sarah White, Executive Director, Multi-Regional Clinical Trials Center of Brigham & Women’s Hospital & Harvard
Ms. Jennifer Ewing, Senior Communications Specialist, Multi-Regional Clinical Trials Center of Brigham & Women’s Hospital & Harvard
Dr. Timothy Rebbeck, Professor, Medical Oncology, Dana-Farber Cancer Institute: Discussion session Moderator
Dr. Kristin Legor, Vice President Clinical Research Nursing Operations, Dana-Farber Cancer Institute
Ms. Doris Sempasa, Program Manager, Center for Cancer Equity and Engagement at Dana-Farber Cancer Institute
Mr. Richard Oakley, Director of Communications, Dana-Farber Cancer Institute
Ms. Maxine Harney, Course Coordinator & Technical Lead for Continuing Professional Development, Mass General Brigham
This activity is not for credit.